https://www.selleckchem.com/products/mrt68921.html
On follow-up magnetic resonance imaging, there was a significant reduction in the number of MS patients developing new contrast enhancing lesions or new T2 lesions. Adverse events (infusion reactions or severe infections) occurred in 12 patients. Rituximab is effective and safe in Indian patients with MS and NMOSD. Rituximab is effective and safe in Indian patients with MS and NMOSD. Epilepsy is the second most common neurological disorder, and it may have a significant effect on sexual functions in epileptic patients. Sexual dysfuncti
Like
Comment
Share
